Podcasts about translational sciences

Introducing Part 4 – New Frontiers in AI & Drug Discovery from Science Will Win.Follow the show: Science Will WinSo far in this season, we've explored how innovations throughout history have brought us to where we are now. We talked about how drug discovery changed from a serendipity-based to data-based endeavor. Then, we explored the powerful hardware and smart software required to accommodate big data. Now, the door to the future of AI in drug discovery is open. In our final episode, we're looking toward the future, to understand where today's advancements could potentially take us. Featured Guests:–Charlotte Allerton, Head of Preclinical and Translational Sciences at Pfizer–Daniel Ziemek, Vice President of Integrative Biology and Systems Immunology at Pfizer–Enoch Huang, Head of Machine Learning and Computational Sciences at Pfizer–Dr. Raza Ali, group leader at the University of Cambridge Cancer Research UK Institute, pathologist Season 4 of Science Will Win is created by Pfizer and hosted by Jeremiah Owyang, entrepreneur, investor, and tech industry analyst. It's produced by Wonder Media Network. DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to team@podroll.fm.

Introducing Part 4 – New Frontiers in AI & Drug Discovery from Science Will Win.Follow the show: Science Will WinSo far in this season, we've explored how innovations throughout history have brought us to where we are now. We talked about how drug discovery changed from a serendipity-based to data-based endeavor. Then, we explored the powerful hardware and smart software required to accommodate big data. Now, the door to the future of AI in drug discovery is open. In our final episode, we're looking toward the future, to understand where today's advancements could potentially take us. Featured Guests:–Charlotte Allerton, Head of Preclinical and Translational Sciences at Pfizer–Daniel Ziemek, Vice President of Integrative Biology and Systems Immunology at Pfizer–Enoch Huang, Head of Machine Learning and Computational Sciences at Pfizer–Dr. Raza Ali, group leader at the University of Cambridge Cancer Research UK Institute, pathologist Season 4 of Science Will Win is created by Pfizer and hosted by Jeremiah Owyang, entrepreneur, investor, and tech industry analyst. It's produced by Wonder Media Network. DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to team@podroll.fm.

Introducing Part 4 – New Frontiers in AI & Drug Discovery from Science Will Win.Follow the show: Science Will WinSo far in this season, we've explored how innovations throughout history have brought us to where we are now. We talked about how drug discovery changed from a serendipity-based to data-based endeavor. Then, we explored the powerful hardware and smart software required to accommodate big data. Now, the door to the future of AI in drug discovery is open. In our final episode, we're looking toward the future, to understand where today's advancements could potentially take us. Featured Guests:–Charlotte Allerton, Head of Preclinical and Translational Sciences at Pfizer–Daniel Ziemek, Vice President of Integrative Biology and Systems Immunology at Pfizer–Enoch Huang, Head of Machine Learning and Computational Sciences at Pfizer–Dr. Raza Ali, group leader at the University of Cambridge Cancer Research UK Institute, pathologist Season 4 of Science Will Win is created by Pfizer and hosted by Jeremiah Owyang, entrepreneur, investor, and tech industry analyst. It's produced by Wonder Media Network. DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to team@podroll.fm.

Episode 54 of The Chemical Sensitivity Podcast is available now! https://www.chemicalsensitivitypodcast.org/It's called: “Women, Dismissal, and Healthcare.”You'll hear Charee M. Thompson, Ph.D.Charee is an associate professor in the Department of Communication at the College of Liberal Arts & Science at the University of Illinois in Urbana-Champaign. She is also an associate professor in the Department of Biomedical & Translational Sciences at the Carle Illinois College of Medicine at the University of Illinois.You'll hear Charee explore how:Women are often blamed and dismissed for their health conditions.Women are frequently excluded from research about health.Women with MCS and other so-called 'contested illnesses" are often dismissed by healthcare workers as well as friends and family.Illnesses such as Multiple Sclerosis were once widely dismissed by healthcare providers. Parents of girls can support their children when they navigate the healthcare system, and more.Thank you for listening! Please subscribe where you get your podcasts and share the podcast with others. About Charee M. Thompson 2023 paper: “Women's Experiences of Health-Related Communicative Disenfranchisement” Authors: Charee M. Thompson, Sara Babu, and Shana MakosDISCLAIMER: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE The information, including but not limited to, text, graphics, images, and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website. No material or information provided by The Chemical Sensitivity Podcast, or its associated website is intended to be a substitute for professional medical advicSupport the Show.Special thanks to the Marilyn Brachman Hoffman Foundation for its generous support of the podcast.If you like the podcast, please consider becoming a supporter! Support the podcast. Find the podcast on Patreon. If you like, please buy me a coffee. Follow the podcast on YouTube! Read captions in any language. Please follow the podcast on social media:FacebookTwitterInstagramTikTokSponsorship Opportunites Are you an organization or company interested in helping to create greater awareness about Multiple Chemical Sensitivity and Chemical Intolerance and/or looking for sponsorship opportunities? Please email us at info@chemicalsensitivitypodcast.org

In this episode, we hear from two physician-scientists who have been leaders in the U.S. effort to deal with two medical crises that emerged almost 40 years apart: HIV/AIDS and COVID-19. Anthony S. Fauci, MD, the recently retired director of the National Institute for Allergy and Infectious Diseases at the National Institutes of Health (NIH), spoke to Washington University School of Medicine's 2023 graduating class. His role at NIH made him a leader in the worldwide effort to understand and develop treatments for HIV/AIDS, beginning shortly after the virus first was recognized. Also, in those early days of HIV/AIDS, William G. Powderly, MD, tested emerging therapies at the School of Medicine's AIDS Clinical Trials Unit, which he oversaw. Powderly, now the Larry J. Shapiro Director of the Institute for Public Health, co-director of the Division of Infectious Diseases, and the J. William Campbell Professor of Medicine and director of the Institute of Clinical and Translational Sciences at the School of Medicine, points to key similarities and differences between the nation's response to HIV/AIDS and to COVID-19. In both cases, he says, the key to a successful response involved embracing science and battling against theories that are untrue. In his Commencement speech, Fauci told the 110 newly minted physicians who graduated this spring that they must push back on destructive forces that dispute science. He advised the new doctors to push back with civility, but also with all of the strength they can muster. While he was at Washington University, Fauci also spoke to the St. Louis press corps about the end of the COVID-19 emergency and where we go from here. The podcast, “Show Me the Science,” is produced by WashU Medicine Marketing & Communications at Washington University School of Medicine in St. Louis.

What is the impact of targeted radiotherapy on the immune system?What are the implications for combination IO?Current approaches and future direction Moderated by: Michael Groaning, PhD, Global Medical Affairs Lead, Genitourinary, Amgen Panelists: Charles Glaus, PhD, Sr Director, Radiomics & Radiology Biomarkers, Bayer US-PharmaceuticalsJeff Legos, PhD, MBA, EVP, Global Head of Oncology & Hematology Development , NovartisMatthew Silva, PhD, CEO , InvicroOhad Ilovich, PhD, Senior Director, Translational Sciences, Curie Therapeutics Learn more about the IO360° Summit at www.io360summit.com

Practical Significance kicks off the new year with its January tradition of featuring the new ASA president. Co-hosts Donna and Ron welcome to the show Dionne Price, the 118th president of the American Statistical Association. Dionne—who is the deputy director of the Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration—shares aspects of her “day” job and her goals for the year ahead. Listen to how an internship sparked her passion for biostatistics and how she puts the FDA and ASA missions ... The post Practical Significance | Episode 25: Meet the New ASA President, Dionne Price first appeared on Amstat News.

Ben Azadi interviews researched from BioSense, Trey Suntrup. We discuss how the body manufactures ketones, the 3 types of ketones, why ketones drop after exercise, and the first breath ketone meter that is accurate. PURCHASE THE BIOSENSE BREATH KETONE METER HERE. USE KETOKAMP AT CHECKOUT FOR $20 OFF. Trey is a researcher and product engineer with over 13 years of experience developing novel device technologies in both academic and industrial settings. He joined Readout from his position as an entrepreneur-in-residence at BioGenerator, a St. Louis based venture capital firm and early Readout investor. Previously Trey was a Translational Sciences and Entrepreneurship fellow at Washington University Medical School in St. Louis, where he helped academic faculty transition commercially promising technologies from the lab to the private sector. He also served as an investment analyst for several venture capital firms in the life sciences. Trey is passionate about partnering with mission-driven founders as they advance new device and digital health technologies to improve patient care. He holds a PhD in physics and electrical engineering from the University of California, Santa Barbara. PURCHASE THE BIOSENSE BREATH KETONE METER HERE. USE KETOKAMP AT CHECKOUT FOR $20 OFF. Order Keto Flex: http://www.ketoflexbook.com Free Keto Masterclass: http://www.ketosismasterclass.com  -------------------------------------------------------- / / E P I S O D E   S P ON S O R S  BiOptimizers Kapex Special Offer: www.kenergize.com/ketokamp Use the code  ketokamp10 for 10% off PureForm Omega Plant Based Oils (Best Alternative to Fish Oil): http://www.purelifescience.com Use ben4 for $4.00 off. Dr Phillips CBD Oil & Keto Fruit Chews. Visit www.drphillipscbd.com Text me the words "Podcast" +1 (786) 364-5002 to be added to my contacts list.  *Some Links Are Affiliates* // F O L L O W ▸ instagram | @thebenazadi | http://bit.ly/2B1NXKW ▸ facebook | /thebenazadi | http://bit.ly/2BVvvW6 ▸ twitter | @thebenazadi http://bit.ly/2USE0so ▸ email | ben@ketokamp.com Disclaimer: This podcast is for information purposes only. Statements and views expressed on this podcast are not medical advice. This podcast including Ben Azadi disclaim responsibility from any possible adverse effects from the use of information contained herein. Opinions of guests are their own, and this podcast does not accept responsibility of statements made by guests. This podcast does not make any representations or warranties about guests qualifications or credibility. Individuals on this podcast may have a direct or non-direct interest in products or services referred to herein. If you think you have a medical problem, consult a licensed physician.

Doug Lindsay has spent the last two decades investigating and tackling rare, complicated medical conditions – first in himself and his family and now through his Personal Medical Consultant service. An innovator, Doug partners with clients and experts to make new things happen. He works to get clients who are stuck in the medical system unstuck. To aid him in his work, he strives to understand healthcare from all levels of organization, from the individual to health systems, public health, and global health. Doug's dogged, indefatigable ability to chase down answers to an individual's complex problems makes him a special asset as a teammate and Personal Medical Consultant. In addition to his Personal Medical Consultant service, Doug Lindsay • Co-chairs PCORI's Congressionally-mandated Rare Disease Advisory Panel (RDAP) • Co-chairs Washington University School of Medicine's Community Advisory Board for the Institute for Clinical and Translational Sciences and the Institute for Public Health (ICTS & IPH). • Is Community Advisory Board member for the National Institutes of Health's ACTIV-1 IM trial. (ACTIV is the US government's public/private/nonprofit collaboration for Accelerating COVID-19 Therapeutics and Vaccines research.) • Is member of the National Institutes of Health's ten-person ACTIV COVID Biospecimen Prioritization Committee. (NIH) • Is member of Academy Health's Global Health Interest Group. • TEDx talk Operation: Adrenal Gland can be found at TED.com • Was speaker in the panel kicking off Academy Health's Datapalooza, 2019 • Has twice been an ePatient Scholar at Stanford Medicine X (2017, 2019) • Appeared on The Dr. OZ Show in fall 2019 as example of The Power of 1 (to make a difference). • Was the first patient invited to give a fireside chat for the Health Management Academy, which hosts C-Suite education conferences for the nation's 100 biggest hospital systems, 2017. • Co-chaired aviation humanitarian nonprofit Wings of Hope's “Taste of Hope” fundraiser • Has been keynote speaker for national organizations like AHIMA, for healthcare conferences like the Society for Participatory Medicine, and at internal corporate events for firms like Pfizer. • Graduated with honors from Rockhurst University's Honors College with a BS in biology in 2016. • CNN online feature “This college dropout was bedridden for 11 years. Then he invented a surgery and cured himself” on his story was the #3 article globally across all media platforms for all of 2019 for time readers spent reading it.

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Elisabeth Heath, Professor of Oncology and Associate Center Director, Translational Sciences, at the Karmanos Cancer Institute. Together they discuss the advances and future of liquid biopsies and their clinical utilization within genitourinary cancers. For more information, please visit: www.CarisLifeSciences.com

Dr. Scott H. Sicherer is the Director of the Elliot and Roslyn Jaffe Food Allergy Institute and the Elliot and Roslyn Jaffe Professor of Pediatric Allergy and Immunology. He is Chief of the Division of Allergy and Immunology in the Department of Pediatrics and Medical Director of the Clinical Research Unit, a component of Conduits-the Institutes for Translational Sciences at Icahn School of Medicine at Mount Sinai. He also authored Food Allergies: A Complete Guide For Eating When Your Life Depends on It. Dr. Sicherer shares with our listeners his incredible wealth of knowledge. Topics covered in this episode include what a reaction may look like, treatment expectations if an ER visit is necessary, oral food challenges (medically supervised feeding), the diagnostic process, causes of food allergies, and much more.  

he event featured experts including Moshe Vardi, Vice President and Global Medicine Team Lead at Alexion Pharmaceuticals, and Aleksandar Skuban, MD, Executive Medical Director for Neurology and Ophthalmology Clinical Development and Translational Sciences at Alexion Pharmaceuticals, Inc. Dr. Vardi explained the role of the immune system as it relates to GMD, or geographical atrophy. Dr. Skuban talked about studies being done to determine efficacy of new treatments, including danicopan, for GMD.

The event featured experts including Moshe Vardi, Vice President and Global Medicine Team Lead at Alexion Pharmaceuticals, and Aleksandar Skuban, MD, Executive Medical Director for Neurology and Ophthalmology Clinical Development and Translational Sciences at Alexion Pharmaceuticals, Inc. Dr. Vardi explained the role of the immune system as it relates to GMD, or geographical atrophy. Dr. Skuban talked about studies being done to determine efficacy of new treatments, including Danicopan, for GMD.

Are you struggling with a C. Diff Infection? Often referred to as C. difficile or C. diff, Clostridioides difficile is a bacterium that can infect your large intestine. It is the most common bacterial infection in hospitals, and in America, between 450,000 to 500,000 people get C. Diff infections every year! In today's episode, we are discussing the signs and symptoms of C. Diff, who can be affected by C. Diff infection, helpful probiotics, and more!- We answer these questions:- What signs and symptoms should you be looking out for?- How does C. Diff affect patients of different ages?- Is C. Diff Infection related to Inflammatory Bowel Disease?- How and where can you contract C. Diff?- What is megacolon?- Does the health of your microbiome affect your odds of infection?- What probiotics can help?- And more!-Connect with Dr. Sahil Khanna:Mayo Clinic: https://www.mayoclinic.org/biographies/khanna-sahil-m-b-b-s-m-s/bio-20097159Twitter :https://twitter.com/khanna_s?lang=en -Schedule a consultation with Alexis:www.altfammed.comSupplementsBinding Fiber Support Capsules - https://drannmariebarter.com/product/binding-fiber-support-capsules/ Binding Fiber Support Powder - https://drannmariebarter.com/product/binding-fiber-support-powder/ - About Dr. Khanna:Dr. Sahil Khanna is a Professor of Medicine in the Division of Gastroenterology and Hepatology at Mayo Clinic, Rochester, MN. He completed Medical School at the All India Institute of Medical Sciences, New Delhi; followed by Post Doctoral Research at University of California San Diego, CA; residency in Internal Medicine and Fellowship in Gastroenterology and Hepatology at Mayo Clinic, Rochester, MN before joining the Faculty. He also completed Masters in Clinical and Translational Sciences during his fellowship. He is directing the Comprehensive Gastroenterology Interest group, C. difficile Clinic, Fecal Microbiota Transplantation program and C. difficile related Clinical Trials at Mayo Clinic, Rochester, MN. He has over 120 publications, serves as reviewer on the editorial board of several journals, and has won numerous awards. -Subscribe for more gut health content and share this podcast with a friend! Take a screenshot of this episode and tag Dr. Ann-Marie Barter:http://instagram.com/drannmariebarter-Dr. Ann-Marie Barter is a Functional Medicine and Chiropractic Doctor at Alternative Family Medicine & Chiropractic. She is the clinic founder of Alternative Family Medicine & Chiropractic that has two offices: one in Longmont and one in Denver. They treat an array of health conditions overlooked or under-treated by conventional medicine, called the "grey zone". https://altfammed.com/https://drannmariebarter.com/

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Elisabeth Heath, Associate Center Director of Translational Sciences at Karmanos Cancer Institute. Together they discuss the latest findings and top abstracts in GU oncology that were presented at this year's ASCO meeting. For more information, please visit: www.CarisLifeSciences.com

In this episode, Ian speaks with Dr. Angela Starkweather, professor of Nursing at UConn School of Nursing and NINR-funded translational pain scientist, about biobehavioral mechanisms of pain and symptom self-management. They also talk at length about maintaining clinical competence as a clinical researcher in nursing science and balancing one's career aspirations across domains.

After recently announcing that vaccinated people could safely take off their masks outdoors and gather in small groups with other vaccinated people indoors, the U.S. Centers for Disease Control and Prevention (CDC) next decided that vaccinated people no longer need to wear masks indoors either. The new guidelines caught many by surprise, but William G. Powderly, MD, the Larry J. Shapiro Director of the Institute for Public Health and co-director of the Division of Infectious Diseases at Washington University School of Medicine in St. Louis, says the new guidelines provide evidence that, for many vaccinated individuals, going without a mask indoors is safe. He says vaccines against the virus are very effective and that although they don’t provide 100% protection, they come pretty close. But Powderly, also director of the university’s Institute of Clinical and Translational Sciences, says people need to remain aware that the pandemic is far from over, that the virus may fight back, and that the CDC may need to change its recommendations again at some point. For now, though, most vaccinated people are fairly safe without masks, he says. On the Washington University Medical Campus, masks still will be required in public areas in hospitals and in clinical areas. The podcast, “Show Me the Science,” is produced by the Office of Medical Public Affairs at Washington University School of Medicine in St. Louis.

Thank you for joining us for another episode of the Low Carb MD Podcast. Dr. Trey Suntrup is a researcher and product engineer with over 13 years of experience working on the development of new device technologies. He holds a PhD in physics and electrical engineering from the University of California, Santa Barbara and has previously worked at Washington University Medical School as a Translational Sciences and Entrepreneurship fellow. He is currently the Head of Product at Readout—creators of the Biosense Breath Ketone Meter. In our discussion with Dr. Suntrup, we talk about the effectiveness of different methods for measuring ketones, the three different types of ketone bodies, at what stages in a given patient’s weight loss/metabolic health journey different ketone measuring devices are useful, how the Biosense breath ketone meter works and what makes it so effective, and the clinical studies involved in the development of the Biosense meter. For more information, please see the links below. Thank you for listening! Links: Biosense Discount Code (good for $30 off the Biosense Breath Ketone Meter): Lowcarb30 Dr. Trey Suntrup: Biosense Website Dr. Brian Lenzkes: Website Dr. Tro Kalayjian: Website

Today we welcome Jeanne Cunicelli, Executive Vice President - UPMC Enterprises. Jeanne, who led Enterprises’ Translational Sciences focus area since 2017, took over as Executive VP this past January. She is a veteran venture capitalist in the life sciences industry, having been a managing director at Bay City Capital in San Francisco before joining UPMC. Under Jeanne's leadership, the Translational Sciences team grew to more than 20 scientific and investment professionals working to accelerate the transfer of scientific discoveries into life-changing medicines, diagnostics and devices. The team formed five startup companies based on University of Pittsburgh research and is expanding its focus nationally and internationally to deploy $1 billion by 2024 in life sciences to grow their portfolio of syndicated investments alongside their company formation efforts.

Dr. Levy, Dr. Phillip Levy, Wayne State University, Assistant Vice President for Translational Sciences and Clinical Research Innovation, and Associate Chair for Research in the Department of Emergency Medicine

COVID-19 vaccine development has been rapid and successful. Two vaccines that report more than 90% efficacy against the virus already are in use, with approval of more vaccines expected in the coming weeks. Meanwhile, the development of treatments for those infected with the virus has been slower. Only one drug, the steroid dexamethasone, has been proven to reduce the risk of death in those hospitalized with COVID-19. In this episode, we’ll hear reasons why the development of effective treatments has progressed so slowly. Discussing this with us is William G. Powderly, MD, the Larry J. Shapiro Director of the Institute for Public Health, co-director of the Division of Infectious Diseases at Washington University School of Medicine in St. Louis and director of the university’s Institute of Clinical and Translational Sciences. He says one reason development of therapies has been slow is because there haven’t been enough big, well-controlled studies. We’ll also hear from Eric J. Lenze, MD, the Wallace and Lucille Renard Professor of Psychiatry, and Angela M. Reiersen, MD, an associate professor of psychiatry. They led a preliminary study at the School of Medicine in which a psychiatric drug was used to keep people with COVID-19 from getting sick enough to be hospitalized. Their study was successful. Now they’re expanding the trial to include COVID-19 patients in all of the United States. The podcast, “Show Me the Science,” is produced by the Office of Medical Public Affairs at Washington University School of Medicine in St. Louis.

Dr. Dena O'Leary is a is a physician in Edmond Oaklahoma, Board certified in Female Pelvic and Reconstructive Surgery, who also has a MS in Clinical and Translational Sciences.  Dr. Dena spent 3 years in academic medicine as faculty at the University of Oklahoma Medical School and spent that time split between teaching, research and patient care.  After figuring out that she did not fit in the academic environment, Dr. Dena found a new job focusing on actual patient care. Dr. Dena cares for women with a variety of pelvic floor concerns, and over the years came to realize that women's healthcare required an integrative approach.In this interview, Dr. Dena, who is one of our fabulous Unlimited Rockstars, talks about some rather misleading myths that are often associated with modern healthcare, nutritional issues in the medical system and the lack of nutrition training in medical school, social inequality in the medical system and how nutrition changed her life and her practice. Make sure to subscribe, rate and comment on the show!For discounts and links to products mentioned on the show:KETO CHOW:http://shop.ketochow.xyz/?aff=81&ref=carriebrown  (10% discount)Paleo Valley   https://amzn.to/2Fx7o4NEnviromedica.   https://amzn.to/32vANoHAncestral Supplements.  https://amzn.to/2H543ucBooks mentioned on the show:Sacred Cow by Rob Wolf  https://amzn.to/3hywJIBThe Vegetarian Myth by Lierre Keith. https://amzn.to/32wqRv2Links to recipes mentioned on the show:Super Mother Clucker Burgers https://carriebrown.com/archives/37806Power Porky Dry Chili Burgers https://carriebrown.com/archives/37804Spicy Beef Liver and Bacon Pate https://carriebrown.com/archives/37231letstruck.comBe sure to rate, subscribe and leave a comment!To support the show and gain access to private groups, rewards, swag, and become a Kitchen or Fatty Joe Show Rockstar, use these links:patreon.com/thefattyjoeshowor patreon.com/carriebrownCheck out our website at thefattyjoeshow.com    If you want to sport some Fatty Joe Show swag like t-shirts coffee mugs and other cool items, go to:https://www.zazzle.com/collections/the_fatty_joe_show-119044829655147361?rf=238386382098264295For recipes, articles, product discounts, Cookbooks, and Cooking Masterclasses go to carriebrown.com     For our YouTube Channel with cooking videos, Vodcast episodes, Keto 101, product reviews, and more go to:https://www.youtube.com/c/TheRealCarrieBrownFacebook page: Carrie Brown and Yogi ParkerMembers Groups: The Keto Kitchen with Carrie Brown and Yogi Parker, Carrie Brown and Yogi Parker's Kitchen Rockstars, The Fatty Joe ShowInstagram: @thefattyjoeshow, @therealcarriebrown, @therealyogiparkerTwitter: @therealcarriebrown, @realyogiparker

It’s possible some people may have been infected earlier, but the first COVID-19 diagnoses in the U.S. occurred in late January. Since then, testing failures, partisan political debates, conspiracy theories and desperate searches for effective treatments have characterized the pandemic response in the United States. However, through all of the noise, scientists have learned quite a bit, according to William G. Powderly, MD, the Larry J. Shapiro Director of the Institute for Public Health and co-director of the Division of Infectious Diseases at Washington University School of Medicine in St. Louis. Powderly, also the J. William Campbell Professor of Medicine and director of the university’s Institute of Clinical and Translational Sciences, is a veteran of the fight against HIV and AIDS. Many of the lessons learned during that epidemic can be applied to the battle against SARS-CoV-2, he said. But a big problem facing the U.S. in its response to the virus is that so many people seem to want simple answers, and simple answers are highly unlikely, he added. And Powderly said we can expect to live with upheaval from the virus until a vaccine is developed. The podcast, “Show Me the Science,” is produced by the Office of Medical Public Affairs at Washington University School of Medicine in St. Louis.

Dr. Glenn Rosen has spent the bulk of his career engaged in basic and translational research in cancer and fibrosis. From 1993-2014, Dr. Rosen held a tenured faculty position in the Division of Pulmonary and Critical Care Medicine, Department of Medicine, Stanford University. He led a basic and translational research laboratory-his research focused on the study of dysregulated signaling in fibrosis and mechanisms of apoptosis resistance in solid tumors. He also led the clinical Interstitial Lung Disease Program at Stanford. Dr. Rosen joined Bristol-Myers Squibb (BMS) in September 2014 as a Medical Director in the Early Clinical and Translational Research Group, where he led the Phase 2 program of a lysophosphatidic acid receptor antagonist for the treatment of pulmonary fibrosis. This was followed by appointment as Therapeutic Area Head of Fibrosis and Genetically Defined Diseases. In 2016 he was selected as Head, Discovery Fibrosis Biology at Bristol-Myers Squibb, where he led the early discovery and development, and translation of pre-clinical compounds, with a disease concentration in liver and lung fibrosis. Dr. Rosen joined Coherus Biosciences, Redwood City, CA, in April, 2019, where he leads the pre-clinical and translational sciences small molecule program, which is focused on development of a novel selective PPARγ modulator for the treatment of NASH.

Ben Azadi interviews researched from BioSense, Trey Suntrup. We discuss how the body manufactures ketones, the 3 types of ketones, why ketones drop after exercise, and the first breath ketone meter that is accurate. PURCHASE THE BIOSENSE BREATH KETONE METER HERE. USE KETOKAMP AT CHECKOUT FOR $20 OFF. Trey is a researcher and product engineer with over 13 years of experience developing novel device technologies in both academic and industrial settings. He joined Readout from his position as an entrepreneur-in-residence at BioGenerator, a St. Louis based venture capital firm and early Readout investor. Previously Trey was a Translational Sciences and Entrepreneurship fellow at Washington University Medical School in St. Louis, where he helped academic faculty transition commercially promising technologies from the lab to the private sector. He also served as an investment analyst for several venture capital firms in the life sciences. Trey is passionate about partnering with mission-driven founders as they advance new device and digital health technologies to improve patient care. He holds a PhD in physics and electrical engineering from the University of California, Santa Barbara. PURCHASE THE BIOSENSE BREATH KETONE METER HERE. USE KETOKAMP AT CHECKOUT FOR $20 OFF. // E P I S O D E   S P ON S O R S  PureForm Omega Plant Based Oils (Best Alternative to Fish Oil): http://www.purelifescience.com Use ben4 for $4.00 off. http://www.Kettleandfire.com/ketokamp and use KETOKAMP at checkout to save 15% on your entire order. // R E S O U R C E S FREE KETO AND FASTING WEBINAR ➡️Check out my Keto Kickstart Kit: http://bit.ly/2okbyUu ➡️Get Your Keto Kamp Apparel: http://www.ketokampgear.com *Some Links Are Affiliates* // F O L L O W ▸ instagram | @thebenazadi | http://bit.ly/2B1NXKW ▸ facebook | /thebenazadi | http://bit.ly/2BVvvW6 ▸ twitter | @thebenazadi http://bit.ly/2USE0so ▸ email | ben@ketokamp.com Disclaimer: This podcast is for information purposes only. Statements and views expressed on this podcast are not medical advice. This podcast including Ben Azadi disclaim responsibility from any possible adverse effects from the use of information contained herein. Opinions of guests are their own, and this podcast does not accept responsibility of statements made by guests. This podcast does not make any representations or warranties about guests qualifications or credibility. Individuals on this podcast may have a direct or non-direct interest in products or services referred to herein. If you think you have a medical problem, consult a licensed physician.

Dr. Dylan Edwards is Director of the Moss Rehabilitation Research Institute as well as an Institute Scientist and Director of the Human Motor Recovery Laboratory there. In addition, he is Professor of Neuroscience at Edith Cowan University in Australia, and Faculty at Harvard Medical Schools Continuing medical education program in Transcranial Magnetic Stimulation. In his research, Dylan studies the recovery of movement following damage to the nervous system that may occur after stroke or spinal cord injury. He and his team use rehabilitation robots to assess and train motor function. They also apply noninvasive stimulation to test the circuitry of the nervous system and as an experimental treatment to augment function. When he’s not at work, you can find Dylan hanging out with his family, enjoying fantastic food, playing the guitar, observing nature, traveling, and thinking about the future of technology and human civilization. He stays active through running and hitting the waves at his favorite surfing destinations around the world. Dylan received a B.App.Sci. degree with a focus in exercise physiology from Edith Cowan University in Australia and a B.S. degree in Physical Therapy from Curtin University of Technology in Australia. He was awarded his PhD in clinical neurophysiology at the Centre for Neuromuscular and Neurological Disorders at the University of Western Australia (now the Perron Institute for Neurological and Translational Sciences), and he conducted postdoctoral research there afterwards. Prior to joining the team at MRRI, Dylan served as Director of the Non-Invasive Brain Stimulation Laboratory at Burke Neurological Institute, and was Associate Professor of Clinical Neurophysiology at Weill Cornell Medicine in New York.

Judy Cameron PhD is a Professor of Psychiatry. This podcast describes ongoing leading public education, intervention and training programs derived from her previous extensive experimental neuroscience research in primate brain development. 

BROWNSVILLE, RGV - The University of Texas Rio Grande Valley and UTHealth in Houston are teaming up to fast track the development of new treatments for disease. The Center for Clinical and Translational Sciences at UTHealth recently announced that is partnering with UTRGV on clinical trials and other research. Joseph McCormick, MD, the director of the center’s clinical research unit in Brownsville, spoke about the new partnership in an exclusive interview with the Rio Grande Guardian.McCormick is a professor with UTHealth School of Public Health in Brownsville and director of the clinical research unit in Brownsville operated by The Center for Clinical and Translational Sciences. “In this new award, one of the areas being developed is for us to be able to do clinical trials,” McCormick said.“This means being able to test new medicines with our population.”McCormick said that currently, a lot of the clinical trials fail to include minority populations.

In this podcast we discuss the evolution of science that is driving the increasing focus on rare indications with Anne Pariser, the Director of the Office of Rare Diseases Research at the National Center for Advancing Translational Sciences (NCATS). Anne is a noted international expert or rare diseases, and has been involved in numerous collaborations within the FDA, as well as with drug developers, governmental agencies, patient groups and other stakeholders in the development of treatments for rare indications. Dr Pariser comes to NCATS from the FDA, where she had worked since 2000 on the development of drug and biological products for orphan and rare conditions. Dr Pariser also served as an associate director in the FDA’s Office of Translational Sciences, which is part of the Center for Drug Evaluation and Research (CDER).

Polycystic ovary syndrome (PCOS) is one of the most ancient disorders (around 50-60,000 years old) and affects up to one in five women regardless of race, nationality or ethnicity. For many women, diagnosis involves a long, enigmatic process including numerous physician visits. Its symptoms are not always clear, the condition has many nuances, and the healthcare system as a whole has a long way to go to be able to provide optimal care for PCOS patients.In this episode, Ricardo Azziz, M.D., M.P.H., M.B.A., renowned physician, researcher, scientist, and Chief Officer of Academic Health and Hospital Affairs, State University of New York (SUNY), joins host Mark P. Trolice, M.D., to break down what PCOS is, why it can be so challenging to diagnose, and the different treatment options available to patients.Tune in to discover:The three main criteria for diagnosing PCOSThe link between PCOS and diabetesThe role of metformin and letrozole in the management of PCOSWhy ovarian drilling gets a bad rap and how it can be an effective treatment for many PCOS patientsAbout Ricardo Azziz, M.D., M.P.H., M.B.A.Ricardo Azziz is an internationally recognized physician, scientist and executive who currently serves as Chief Officer, Academic Health & Hospital Affairs, the State University of New York (SUNY), the largest university system in the nation. Dr. Azziz's biomedical research focuses on the study of reproductive endocrinology and androgen excess disorders. He has published over 500 original peer-reviewed articles, book chapters and reviews and is consistently ranked one of America's Top Doctors. He has received, among other recognitions, the 2000 President's Achievement Award of the Society for Gynecologic Investigation, and was elected member of the Association of American Physicians.He previously served as deputy director of the Clinical & Translational Sciences Institute and assistant dean for Clinical and Translational Sciences at UCLA, and director of the Center for Androgen-Related Disorders at Cedars-Sinai Medical Center, Los Angeles. He is the founder and serves as senior executive director of the Androgen Excess & PCOS Society.Among other advisory capacities, he served on multiple NIH committees, chaired the U.S. FDA Advisory Board on Reproductive Health Drugs and served on the oversight committee for the California Institute for Regenerative Medicine. Dr. Azziz previously also served as president of Georgia Health Sciences University and then founding president of Georgia Regents University, one of Georgia's four comprehensive research-level universities. He also served as founding CEO of the Georgia Regents Health System, the state's only public academic health center.About Mark P. Trolice, M.D.Mark P. Trolice, M.D., FACOG, FACS, FACE is Director of Fertility CARE: The IVF Center in Winter Park, Florida and Associate Professor of Obstetrics & Gynecology (OB/GYN) at the University of Central Florida College of Medicine in Orlando responsible for the medical education of OB/GYN residents and medical students as well as Medical Endocrinology fellows. He is past President of the Florida Society of Reproductive Endocrinology & Infertility (REI) and past Division Director of REI at Winnie Palmer Hospital, part of Orlando Health. He is double Board-certified in REI and OB/GYN, maintains annual recertification, and has been awarded the American Medical Association’s “Physicians’ Recognition Award” annually. He holds the unique distinction of being a Fellow in all three American Colleges of OB/GYN, of Surgeons, and of Endocrinology. His colleagues select him as Top Doctor in America® annually, one among the top 5% of doctors in the U.S. In 2018, he was awarded the&

Sherri interviews UAB Comprehensive Cancer Center Radiation Oncologist Dr. Eddy Yang who is a professor and Vice Chair of Translational Sciences in UAB's Comprehensive Cancer Center and ROAR Southeast Cancer Foundation Endowed Chair. We explore cancer staging and the new TNM system. And discuss the the three sub-types of breast cancer: Estrogren Receptor positive, Her2 positive, and Triple Negative.

Dealing across several medical and scientific domains, the National Center for Advancing Translational Sciences, part of the National Institutes of Health, is a highly data-driven organization. Sam Michael is chief of the information technology resources branch at N-CATS, joined Federal Drive with Tom Temin for an update on its data and cloud strategies.

Regenerative Medicine Today welcomes Dr. Morgan Fedorchak. Dr. Fedorchak is an Assistant Professor of Ophthalmology, Chemical Engineering, and Clinical & Translational Sciences at the University of Pittsburgh. She is also the Director of the Ophthalmic Biomaterials Laboratory at Pitt and is affiliated with the Louis J. Fox Center for Vision Restoration. Dr. Fedorchak [...]